Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mybl1
|
ENSMUSG00000025912.10 | myeloblastosis oncogene-like 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_9701919_9702070 | Mybl1 | 1785 | 0.301449 | 0.27 | 3.6e-02 | Click! |
chr1_9698347_9698560 | Mybl1 | 1201 | 0.423522 | -0.24 | 6.1e-02 | Click! |
chr1_9698748_9698933 | Mybl1 | 814 | 0.577049 | -0.14 | 3.0e-01 | Click! |
chr1_9722366_9722517 | Mybl1 | 22232 | 0.124171 | -0.12 | 3.6e-01 | Click! |
chr1_9699781_9700262 | Mybl1 | 3 | 0.973078 | -0.01 | 9.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_75384437_75388058 | 10.28 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr11_97439854_97442222 | 10.04 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr8_120292266_120293650 | 8.80 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr15_103253562_103255772 | 7.08 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr10_67002257_67005140 | 7.05 |
Gm31763 |
predicted gene, 31763 |
1322 |
0.45 |
chr17_36869615_36870619 | 6.98 |
Trim10 |
tripartite motif-containing 10 |
543 |
0.55 |
chr16_58674023_58674421 | 6.66 |
Cpox |
coproporphyrinogen oxidase |
86 |
0.96 |
chr8_57320946_57324000 | 6.60 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr13_37853981_37855228 | 5.58 |
Rreb1 |
ras responsive element binding protein 1 |
3330 |
0.26 |
chr6_31125380_31126701 | 5.45 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr8_121082801_121085531 | 5.42 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr4_119188012_119188665 | 5.42 |
Ermap |
erythroblast membrane-associated protein |
409 |
0.69 |
chr4_134094288_134094993 | 5.27 |
Cd52 |
CD52 antigen |
398 |
0.73 |
chr18_35847749_35850271 | 5.22 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr3_14887713_14888243 | 5.18 |
Car2 |
carbonic anhydrase 2 |
1339 |
0.44 |
chr7_110773542_110774597 | 5.18 |
Ampd3 |
adenosine monophosphate deaminase 3 |
175 |
0.93 |
chr14_32167841_32168504 | 5.17 |
Ncoa4 |
nuclear receptor coactivator 4 |
2051 |
0.19 |
chr8_94172106_94173724 | 5.11 |
Mt2 |
metallothionein 2 |
55 |
0.87 |
chr2_173024069_173026002 | 5.08 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr11_102895188_102895912 | 5.05 |
Gfap |
glial fibrillary acidic protein |
1581 |
0.23 |
chr6_41703661_41704308 | 5.04 |
Kel |
Kell blood group |
355 |
0.81 |
chr15_98601965_98602724 | 5.00 |
Adcy6 |
adenylate cyclase 6 |
2387 |
0.14 |
chr11_84825899_84826527 | 4.99 |
Dhrs11 |
dehydrogenase/reductase (SDR family) member 11 |
2751 |
0.16 |
chr10_80856664_80858456 | 4.87 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr19_5842574_5845856 | 4.85 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr2_170151444_170151715 | 4.84 |
Zfp217 |
zinc finger protein 217 |
3476 |
0.35 |
chr15_102002686_102004263 | 4.82 |
Gm36026 |
predicted gene, 36026 |
738 |
0.42 |
chr9_31255780_31256160 | 4.81 |
Gm7244 |
predicted gene 7244 |
18851 |
0.15 |
chr17_70850387_70852082 | 4.80 |
Tgif1 |
TGFB-induced factor homeobox 1 |
27 |
0.95 |
chr17_84185673_84188034 | 4.73 |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
1094 |
0.34 |
chr11_65649711_65650176 | 4.73 |
Gm26128 |
predicted gene, 26128 |
23549 |
0.21 |
chr9_22131114_22132438 | 4.73 |
Acp5 |
acid phosphatase 5, tartrate resistant |
39 |
0.93 |
chr3_152189105_152190257 | 4.70 |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
4164 |
0.14 |
chr2_173033564_173034786 | 4.68 |
Gm14453 |
predicted gene 14453 |
405 |
0.79 |
chr11_58918085_58918881 | 4.68 |
Btnl10 |
butyrophilin-like 10 |
426 |
0.61 |
chr11_54026747_54027441 | 4.66 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
858 |
0.54 |
chr14_121731598_121732591 | 4.60 |
Dock9 |
dedicator of cytokinesis 9 |
6767 |
0.27 |
chr3_14889110_14890285 | 4.58 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr7_99594627_99596228 | 4.56 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr19_43784066_43785041 | 4.52 |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
2227 |
0.24 |
chr11_83065104_83067047 | 4.46 |
Slfn2 |
schlafen 2 |
963 |
0.31 |
chr2_158145151_158146425 | 4.46 |
Tgm2 |
transglutaminase 2, C polypeptide |
578 |
0.71 |
chr9_70847519_70848229 | 4.41 |
Gm3436 |
predicted pseudogene 3436 |
4702 |
0.24 |
chr2_32078207_32079756 | 4.39 |
Fam78a |
family with sequence similarity 78, member A |
371 |
0.77 |
chr8_122546551_122549259 | 4.37 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr11_6519149_6520926 | 4.35 |
Myo1g |
myosin IG |
533 |
0.57 |
chr14_75178051_75179727 | 4.34 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2681 |
0.23 |
chr3_153908033_153909893 | 4.33 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chr9_108110482_108111977 | 4.26 |
Bsn |
bassoon |
816 |
0.36 |
chr16_44015370_44016774 | 4.24 |
Gramd1c |
GRAM domain containing 1C |
364 |
0.83 |
chr12_111442182_111444685 | 4.21 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr8_34096835_34098006 | 4.18 |
Dctn6 |
dynactin 6 |
271 |
0.85 |
chr8_84701273_84703379 | 4.17 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr2_79257648_79258440 | 4.17 |
Itga4 |
integrin alpha 4 |
2097 |
0.38 |
chr8_94985246_94986199 | 4.16 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr14_51130108_51130570 | 4.13 |
Rnase6 |
ribonuclease, RNase A family, 6 |
1258 |
0.24 |
chr6_117888079_117889227 | 4.13 |
Gm29509 |
predicted gene 29509 |
10548 |
0.11 |
chr10_120363772_120364466 | 4.12 |
1700006J14Rik |
RIKEN cDNA 1700006J14 gene |
38 |
0.97 |
chr10_42273694_42273969 | 4.12 |
Foxo3 |
forkhead box O3 |
2865 |
0.34 |
chr17_29493756_29495031 | 4.11 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr8_82401863_82403222 | 3.98 |
Il15 |
interleukin 15 |
28 |
0.98 |
chr19_45447201_45447888 | 3.97 |
Btrc |
beta-transducin repeat containing protein |
2036 |
0.3 |
chr5_86904847_86905140 | 3.94 |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
1944 |
0.2 |
chr14_75176818_75177839 | 3.94 |
Lcp1 |
lymphocyte cytosolic protein 1 |
1120 |
0.45 |
chr3_131269218_131269951 | 3.94 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
2440 |
0.24 |
chr2_105125289_105128976 | 3.93 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr4_15268528_15269161 | 3.93 |
Tmem64 |
transmembrane protein 64 |
3013 |
0.35 |
chr3_102165384_102165916 | 3.89 |
Vangl1 |
VANGL planar cell polarity 1 |
290 |
0.87 |
chr10_93142710_93143193 | 3.89 |
Cdk17 |
cyclin-dependent kinase 17 |
17924 |
0.17 |
chr10_62341499_62342686 | 3.84 |
Hk1 |
hexokinase 1 |
607 |
0.63 |
chr10_37139080_37141738 | 3.84 |
5930403N24Rik |
RIKEN cDNA 5930403N24 gene |
495 |
0.74 |
chrX_48146526_48147857 | 3.84 |
Sash3 |
SAM and SH3 domain containing 3 |
755 |
0.65 |
chr11_7197824_7198759 | 3.83 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
509 |
0.77 |
chr6_86078066_86079298 | 3.82 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr13_45511663_45511958 | 3.80 |
Gmpr |
guanosine monophosphate reductase |
2030 |
0.37 |
chr9_21029266_21030734 | 3.80 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr8_84703616_84705950 | 3.76 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr7_105762080_105763247 | 3.75 |
Gm15645 |
predicted gene 15645 |
342 |
0.76 |
chr7_142654280_142656231 | 3.73 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chr19_32237520_32237692 | 3.72 |
Sgms1 |
sphingomyelin synthase 1 |
1206 |
0.54 |
chr11_87725925_87727087 | 3.72 |
Rnf43 |
ring finger protein 43 |
920 |
0.38 |
chr6_72390793_72390963 | 3.71 |
Vamp8 |
vesicle-associated membrane protein 8 |
175 |
0.9 |
chr6_90620779_90621252 | 3.69 |
Slc41a3 |
solute carrier family 41, member 3 |
1868 |
0.26 |
chr8_122536554_122537967 | 3.66 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
14069 |
0.09 |
chr1_171561765_171562057 | 3.65 |
Cd244a |
CD244 molecule A |
2717 |
0.14 |
chr9_14378940_14379551 | 3.63 |
Endod1 |
endonuclease domain containing 1 |
1738 |
0.24 |
chr12_78911183_78912290 | 3.62 |
Plek2 |
pleckstrin 2 |
4772 |
0.2 |
chr12_95693703_95697493 | 3.60 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
241 |
0.92 |
chr6_121336823_121337558 | 3.58 |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
5886 |
0.17 |
chr4_117473269_117473989 | 3.58 |
Rnf220 |
ring finger protein 220 |
21382 |
0.13 |
chr3_84477728_84478854 | 3.58 |
Fhdc1 |
FH2 domain containing 1 |
691 |
0.74 |
chr8_57324709_57326732 | 3.56 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr15_80081790_80082065 | 3.56 |
Rpl3 |
ribosomal protein L3 |
656 |
0.39 |
chr5_75148315_75152589 | 3.56 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr6_120618968_120619160 | 3.54 |
Gm44124 |
predicted gene, 44124 |
38888 |
0.11 |
chr13_94709555_94711133 | 3.53 |
Gm32351 |
predicted gene, 32351 |
7626 |
0.16 |
chr13_24419516_24419736 | 3.53 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2402 |
0.22 |
chr9_107590316_107591253 | 3.52 |
Ifrd2 |
interferon-related developmental regulator 2 |
323 |
0.64 |
chr7_75612178_75613652 | 3.51 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr2_28619027_28619457 | 3.48 |
Gfi1b |
growth factor independent 1B |
2703 |
0.16 |
chr8_104963800_104964181 | 3.48 |
Ces2g |
carboxylesterase 2G |
2215 |
0.17 |
chrX_169915854_169917220 | 3.48 |
Mid1 |
midline 1 |
10414 |
0.22 |
chr16_91805843_91806547 | 3.47 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
1559 |
0.38 |
chr2_24385363_24386049 | 3.46 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
353 |
0.84 |
chr7_30493583_30494737 | 3.45 |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
380 |
0.63 |
chr1_130421898_130423113 | 3.45 |
Cd55b |
CD55 molecule, decay accelerating factor for complement B |
235 |
0.58 |
chr11_78075318_78075753 | 3.45 |
Eral1 |
Era (G-protein)-like 1 (E. coli) |
436 |
0.61 |
chr5_110836247_110836790 | 3.44 |
Hscb |
HscB iron-sulfur cluster co-chaperone |
198 |
0.9 |
chr11_83285353_83286025 | 3.43 |
Slfn14 |
schlafen 14 |
1037 |
0.31 |
chr4_154926952_154928851 | 3.42 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr11_102360845_102363484 | 3.41 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr2_160603365_160603863 | 3.40 |
Gm14221 |
predicted gene 14221 |
16357 |
0.16 |
chr5_105527486_105528761 | 3.40 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
8650 |
0.2 |
chr2_155612818_155614078 | 3.38 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
2236 |
0.14 |
chr3_127123282_127124895 | 3.37 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr18_32557788_32558922 | 3.37 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr11_118401030_118402004 | 3.35 |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
335 |
0.84 |
chr3_135607346_135607932 | 3.35 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
631 |
0.72 |
chr8_68120390_68121526 | 3.35 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
355 |
0.92 |
chr11_103102696_103105788 | 3.35 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr14_70706940_70707491 | 3.34 |
Xpo7 |
exportin 7 |
820 |
0.57 |
chr10_86023427_86024178 | 3.33 |
A230060F14Rik |
RIKEN cDNA A230060F14 gene |
1473 |
0.24 |
chr4_134869303_134870057 | 3.32 |
Rhd |
Rh blood group, D antigen |
5144 |
0.18 |
chr17_31208121_31208604 | 3.31 |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
271 |
0.86 |
chr4_115048014_115048670 | 3.31 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
8084 |
0.16 |
chrX_137118132_137120673 | 3.29 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr7_98176104_98177065 | 3.26 |
Gm16938 |
predicted gene, 16938 |
610 |
0.62 |
chr6_122391330_122392825 | 3.25 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
698 |
0.58 |
chr15_36643807_36644177 | 3.24 |
Gm6704 |
predicted gene 6704 |
14123 |
0.13 |
chr18_38247513_38247944 | 3.24 |
1700086O06Rik |
RIKEN cDNA 1700086O06 gene |
2150 |
0.16 |
chr10_89532535_89533889 | 3.23 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
373 |
0.88 |
chr5_139390751_139391547 | 3.21 |
Gpr146 |
G protein-coupled receptor 146 |
1364 |
0.29 |
chr10_59873887_59874700 | 3.21 |
Gm7413 |
predicted gene 7413 |
2611 |
0.21 |
chr6_5255342_5256653 | 3.20 |
Pon3 |
paraoxonase 3 |
217 |
0.93 |
chr17_12766020_12767485 | 3.20 |
Igf2r |
insulin-like growth factor 2 receptor |
2912 |
0.17 |
chr19_29126810_29127736 | 3.19 |
Mir101b |
microRNA 101b |
8006 |
0.14 |
chr19_32209821_32211372 | 3.19 |
Sgms1 |
sphingomyelin synthase 1 |
417 |
0.79 |
chr17_35131032_35132104 | 3.18 |
Apom |
apolipoprotein M |
482 |
0.44 |
chr12_69373781_69374122 | 3.18 |
Gm9887 |
predicted gene 9887 |
1483 |
0.22 |
chr10_127177539_127178955 | 3.18 |
Slc26a10 |
solute carrier family 26, member 10 |
1258 |
0.23 |
chr10_127509222_127511152 | 3.17 |
Stac3 |
SH3 and cysteine rich domain 3 |
2962 |
0.13 |
chr2_173021971_173023356 | 3.17 |
Rbm38 |
RNA binding motif protein 38 |
168 |
0.65 |
chr2_127364227_127365175 | 3.17 |
Adra2b |
adrenergic receptor, alpha 2b |
1415 |
0.34 |
chr12_91745342_91746056 | 3.16 |
Ston2 |
stonin 2 |
385 |
0.85 |
chr8_122282630_122283784 | 3.16 |
Zfpm1 |
zinc finger protein, multitype 1 |
1066 |
0.46 |
chr8_104535337_104535640 | 3.16 |
Car7 |
carbonic anhydrase 7 |
788 |
0.34 |
chr4_134868590_134868926 | 3.15 |
Rhd |
Rh blood group, D antigen |
4222 |
0.19 |
chr12_32111429_32112319 | 3.15 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
11828 |
0.18 |
chr11_102364387_102365146 | 3.15 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
481 |
0.67 |
chr15_78571734_78572724 | 3.14 |
Rac2 |
Rac family small GTPase 2 |
552 |
0.62 |
chr11_117779316_117780928 | 3.14 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr6_48571388_48572885 | 3.14 |
Rarres2 |
retinoic acid receptor responder (tazarotene induced) 2 |
510 |
0.53 |
chr8_110932397_110932741 | 3.13 |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
648 |
0.57 |
chr1_36309057_36309739 | 3.13 |
Arid5a |
AT rich interactive domain 5A (MRF1-like) |
1619 |
0.29 |
chr9_89879614_89881129 | 3.13 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
29537 |
0.16 |
chr15_79891602_79892946 | 3.12 |
Apobec3 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
129 |
0.93 |
chr14_69278101_69278489 | 3.12 |
Gm20236 |
predicted gene, 20236 |
3845 |
0.11 |
chr12_117657998_117660727 | 3.12 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr1_156615340_156616247 | 3.12 |
Abl2 |
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
130 |
0.96 |
chr14_69496349_69496737 | 3.11 |
Gm37094 |
predicted gene, 37094 |
3847 |
0.12 |
chr6_135205239_135205560 | 3.11 |
Fam234b |
family with sequence similarity 234, member B |
6987 |
0.12 |
chr10_80419816_80420341 | 3.11 |
Tcf3 |
transcription factor 3 |
1782 |
0.16 |
chr1_75217955_75219308 | 3.10 |
Tuba4a |
tubulin, alpha 4A |
7 |
0.92 |
chrX_101377313_101377922 | 3.10 |
Gjb1 |
gap junction protein, beta 1 |
344 |
0.84 |
chr6_49208234_49209239 | 3.09 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
5425 |
0.17 |
chr2_10306713_10307364 | 3.09 |
Sfmbt2 |
Scm-like with four mbt domains 2 |
63472 |
0.03 |
chr6_72391190_72391463 | 3.07 |
Vamp8 |
vesicle-associated membrane protein 8 |
623 |
0.55 |
chr5_67813721_67814007 | 3.06 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
1366 |
0.35 |
chr1_85735264_85735792 | 3.05 |
A630001G21Rik |
RIKEN cDNA A630001G21 gene |
1026 |
0.4 |
chr5_23921352_23921520 | 3.05 |
Fam126a |
family with sequence similarity 126, member A |
1468 |
0.33 |
chr8_23042468_23042927 | 3.05 |
Ank1 |
ankyrin 1, erythroid |
7466 |
0.18 |
chr12_7978894_7979569 | 3.04 |
Apob |
apolipoprotein B |
1452 |
0.45 |
chr9_72410185_72410545 | 3.04 |
BC065403 |
cDNA sequence BC065403 |
420 |
0.6 |
chr10_127749619_127751660 | 3.04 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr9_50692780_50693781 | 3.03 |
Dixdc1 |
DIX domain containing 1 |
519 |
0.7 |
chr12_109455257_109457986 | 3.02 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
2426 |
0.16 |
chr7_144788494_144788859 | 3.02 |
Gm34964 |
predicted gene, 34964 |
3132 |
0.15 |
chr6_86079772_86080184 | 3.02 |
Add2 |
adducin 2 (beta) |
1894 |
0.25 |
chr12_103390074_103390368 | 3.01 |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
1236 |
0.29 |
chr18_35626329_35627080 | 3.01 |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
492 |
0.6 |
chr13_23501931_23502465 | 3.00 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
13341 |
0.06 |
chr5_124049658_124050948 | 3.00 |
Gm43661 |
predicted gene 43661 |
2049 |
0.18 |
chr4_144892505_144894616 | 2.99 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
341 |
0.9 |
chr9_63756717_63758746 | 2.99 |
Smad3 |
SMAD family member 3 |
263 |
0.93 |
chr13_51646613_51647088 | 2.98 |
Gm22806 |
predicted gene, 22806 |
1349 |
0.33 |
chr10_77112255_77113959 | 2.98 |
Col18a1 |
collagen, type XVIII, alpha 1 |
598 |
0.73 |
chr16_38371842_38372227 | 2.96 |
Popdc2 |
popeye domain containing 2 |
36 |
0.96 |
chr3_60031760_60032307 | 2.96 |
Aadac |
arylacetamide deacetylase |
157 |
0.95 |
chr17_28007198_28009699 | 2.96 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
1103 |
0.37 |
chr8_27177069_27177905 | 2.95 |
Rab11fip1 |
RAB11 family interacting protein 1 (class I) |
2841 |
0.14 |
chr13_51647699_51648388 | 2.94 |
Gm22806 |
predicted gene, 22806 |
156 |
0.94 |
chr17_71214561_71214955 | 2.94 |
Lpin2 |
lipin 2 |
10082 |
0.17 |
chr8_13037819_13038703 | 2.94 |
F10 |
coagulation factor X |
423 |
0.7 |
chr11_117798237_117798922 | 2.93 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
919 |
0.33 |
chr8_57319308_57320679 | 2.92 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr2_30418468_30419623 | 2.92 |
Ptpa |
protein phosphatase 2 protein activator |
2743 |
0.14 |
chr9_42461646_42462435 | 2.92 |
Tbcel |
tubulin folding cofactor E-like |
579 |
0.73 |
chr10_25298849_25299177 | 2.91 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
94 |
0.83 |
chr17_25961783_25962611 | 2.90 |
Capn15 |
calpain 15 |
1563 |
0.17 |
chr11_120628644_120631479 | 2.89 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
87 |
0.89 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0036394 | amylase secretion(GO:0036394) |
2.2 | 6.7 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.2 | 6.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.2 | 10.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.1 | 6.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.9 | 1.9 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.9 | 5.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.8 | 7.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.8 | 5.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.7 | 6.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.7 | 1.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.7 | 1.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.6 | 6.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.5 | 4.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.5 | 3.1 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
1.5 | 9.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.5 | 4.5 | GO:0018343 | protein farnesylation(GO:0018343) |
1.5 | 4.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.5 | 6.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.5 | 4.4 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.5 | 7.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.4 | 7.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.4 | 7.1 | GO:0070836 | caveola assembly(GO:0070836) |
1.4 | 4.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.4 | 4.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 4.0 | GO:0050904 | diapedesis(GO:0050904) |
1.3 | 4.0 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.3 | 4.0 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.3 | 2.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.3 | 6.4 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
1.3 | 3.8 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.3 | 2.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.3 | 3.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.3 | 3.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.2 | 10.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.2 | 6.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.2 | 3.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.2 | 2.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.2 | 3.5 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.2 | 3.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 4.6 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.1 | 3.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 5.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.1 | 4.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.1 | 5.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 23.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.1 | 3.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.1 | 4.4 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.1 | 3.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.1 | 4.3 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
1.1 | 5.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
1.1 | 3.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.1 | 3.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.1 | 5.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
1.1 | 3.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.1 | 3.2 | GO:0008228 | opsonization(GO:0008228) |
1.1 | 6.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.0 | 3.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.0 | 4.1 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.0 | 5.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 7.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
1.0 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.0 | 4.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.0 | 2.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.0 | 3.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.0 | 3.0 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.0 | 3.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 2.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 1.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.0 | 2.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 3.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.9 | 3.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.9 | 3.8 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.9 | 3.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.9 | 5.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.9 | 1.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.9 | 3.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 2.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.9 | 2.7 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.9 | 4.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.9 | 2.6 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.9 | 0.9 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.9 | 1.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.9 | 0.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.9 | 2.6 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.8 | 3.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.8 | 2.5 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.8 | 2.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.8 | 3.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.8 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 2.5 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.8 | 2.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.8 | 4.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.8 | 3.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.8 | 10.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.8 | 2.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 3.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.8 | 2.4 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 7.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.8 | 2.4 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.8 | 3.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 4.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 2.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.8 | 1.6 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.8 | 0.8 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.8 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 3.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.8 | 2.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 3.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 6.2 | GO:0097286 | iron ion import(GO:0097286) |
0.8 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.8 | 3.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 5.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.7 | 0.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.7 | 5.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.7 | 2.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 5.2 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 2.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.7 | 2.2 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.7 | 2.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.7 | 2.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.7 | 0.7 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.7 | 1.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 0.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.7 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 2.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.7 | 2.8 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 2.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.7 | 2.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.7 | 1.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 3.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 2.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.7 | 2.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.7 | 2.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 2.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.7 | 2.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.7 | 2.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 3.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 1.4 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.7 | 4.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 0.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 2.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 2.7 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.7 | 0.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 2.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 1.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.7 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 0.7 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.7 | 2.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.6 | 2.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 5.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.6 | 9.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.6 | 1.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 2.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 2.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 7.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.6 | 3.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 1.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.6 | 0.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.6 | 1.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 5.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.6 | 1.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 1.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 1.9 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 3.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.6 | 1.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.6 | 4.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 1.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.6 | 1.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 0.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 2.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 1.8 | GO:0061010 | gall bladder development(GO:0061010) |
0.6 | 1.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 1.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.6 | 0.6 | GO:1901656 | glycoside transport(GO:1901656) |
0.6 | 7.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 2.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 1.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 2.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.6 | 5.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 0.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.6 | 1.7 | GO:0045472 | response to ether(GO:0045472) |
0.6 | 1.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 1.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.6 | 2.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 1.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 4.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.6 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.6 | 1.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 2.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 2.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 1.1 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.6 | 1.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 1.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 1.7 | GO:0046618 | drug export(GO:0046618) |
0.6 | 0.6 | GO:0003097 | renal water transport(GO:0003097) |
0.6 | 1.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.6 | 1.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.6 | 0.6 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.6 | 1.7 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.6 | 0.6 | GO:0051025 | negative regulation of immunoglobulin production(GO:0002638) negative regulation of immunoglobulin secretion(GO:0051025) |
0.6 | 1.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.6 | 1.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 1.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.5 | 3.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 0.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.5 | 4.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 2.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.5 | 3.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 0.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.5 | 2.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.5 | 2.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 2.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.5 | 5.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 1.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 2.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 3.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 2.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 1.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 0.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.5 | 2.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.5 | 3.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 2.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.5 | 1.5 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 1.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.5 | 1.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 5.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 2.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.5 | 3.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 1.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 1.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 2.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 1.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 1.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 0.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 1.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.5 | 1.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 2.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 2.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.5 | 2.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.5 | 1.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 0.5 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.5 | 0.5 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.5 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 2.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 2.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.5 | 1.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 2.9 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.5 | 2.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 1.4 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.5 | 0.5 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.5 | 1.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 1.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 3.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.5 | 2.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 1.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.9 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 0.9 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.5 | 2.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 1.9 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.5 | 2.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 0.5 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.5 | 1.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.5 | 0.5 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.5 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 1.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 1.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 1.8 | GO:0018214 | protein carboxylation(GO:0018214) |
0.5 | 1.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 6.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 1.8 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.5 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.5 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 0.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.5 | 1.4 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.5 | 0.9 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.5 | 0.5 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.5 | 3.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.9 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 4.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 1.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 2.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.4 | 2.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.4 | 1.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.4 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 2.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 0.9 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 2.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 2.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 1.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.4 | 1.7 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 1.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 2.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 0.4 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.4 | 2.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.4 | 1.3 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.4 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 3.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 1.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.4 | 1.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 0.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 1.3 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 2.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 0.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 3.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 2.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 0.8 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 2.9 | GO:0006560 | proline metabolic process(GO:0006560) |
0.4 | 1.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 2.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 1.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.4 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 2.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 2.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.4 | 0.8 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 2.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.4 | 1.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.4 | 1.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 0.4 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 0.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.4 | 1.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.4 | 2.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.4 | 2.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.4 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 3.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.4 | 1.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 0.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 1.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.4 | 1.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 2.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.4 | 1.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 1.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 3.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 1.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 1.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.4 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 4.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.4 | 2.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 0.8 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.4 | 3.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.4 | 0.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 | 0.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.4 | 1.9 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.4 | 1.9 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 1.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.4 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 0.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 2.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 5.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 2.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 1.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 1.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 1.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 2.9 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.4 | 1.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.4 | 1.5 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 6.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 2.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 0.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 3.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 1.8 | GO:1901563 | response to camptothecin(GO:1901563) |
0.4 | 0.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 2.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 2.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.4 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.4 | 0.4 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.4 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 3.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 1.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.4 | 1.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 1.1 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 1.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 1.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 1.4 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.4 | 3.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 6.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 2.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 2.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 0.7 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 6.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 4.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 3.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 4.8 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 1.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.3 | 1.4 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 2.0 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.3 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 5.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 1.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 1.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 3.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 0.7 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 2.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 2.6 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 1.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 1.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 2.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 0.6 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.0 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.3 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.9 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.3 | 1.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 1.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 1.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 3.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 1.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 0.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 1.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 3.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 2.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.9 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 2.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 0.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 1.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 3.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 0.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.6 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 1.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 0.3 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 3.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 3.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 13.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 1.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 1.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 1.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 7.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 0.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 1.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 2.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.8 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 2.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.6 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.9 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.3 | 4.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.2 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 0.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 1.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 1.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 1.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.3 | 3.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.9 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 5.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 1.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 1.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.8 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.3 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 1.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.6 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.3 | 0.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 1.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.3 | 1.9 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.3 | 1.4 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 9.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.3 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.3 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 3.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.3 | GO:0060416 | response to growth hormone(GO:0060416) |
0.3 | 0.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.3 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 1.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 1.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 4.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 5.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 1.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 1.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 1.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 1.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 0.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.3 | 0.3 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.3 | 0.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.3 | 2.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.8 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.3 | 1.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 0.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.3 | 0.8 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 0.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.3 | 0.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.5 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.3 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 1.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 0.8 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.3 | 0.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 2.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 9.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 2.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 4.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 2.9 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.2 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 3.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 1.9 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.9 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.2 | 1.2 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 1.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.9 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.5 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.2 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.7 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 1.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 2.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 1.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 3.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 1.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.9 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 0.5 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.7 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.2 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 1.6 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.2 | 0.7 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.2 | 0.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 2.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 2.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 | 3.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 3.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.4 | GO:0031100 | organ regeneration(GO:0031100) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 1.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 7.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 2.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 4.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.2 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 1.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 1.7 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.2 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 2.3 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 4.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.2 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 2.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 1.6 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 1.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 1.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 7.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.8 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.2 | 0.4 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 6.6 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 1.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 3.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.6 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.2 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 3.0 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 1.4 | GO:0033522 | histone H2A ubiquitination(GO:0033522) histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 4.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 2.1 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 1.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.2 | GO:1904748 | regulation of apoptotic process involved in development(GO:1904748) |
0.2 | 0.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.6 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 2.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 1.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.1 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 1.1 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 5.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 4.0 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 1.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 2.0 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 1.5 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.2 | 1.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 0.7 | GO:0006569 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.2 | 1.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.7 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 1.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 7.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.5 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 1.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.3 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 1.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.2 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.7 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.2 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.2 | 0.2 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.2 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 1.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 1.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 1.7 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 1.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 1.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 1.0 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 1.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 1.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 5.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 1.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 3.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 4.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 2.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 1.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.9 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.2 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 1.7 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 2.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 2.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.8 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 5.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 5.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 1.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 2.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0035246 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 1.2 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.6 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 6.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 3.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.1 | 0.1 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.6 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 1.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.1 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 2.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 1.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.7 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 6.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 0.7 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 1.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.1 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.1 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.5 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.8 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.1 | 0.5 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.1 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 2.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 1.3 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 1.0 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.1 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.1 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 1.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 4.0 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.5 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 3.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 2.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 4.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.5 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 1.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 1.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.3 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.4 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0052248 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.5 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 1.9 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 1.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 1.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 1.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 1.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.5 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 2.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 1.4 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 0.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.4 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 1.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.4 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 1.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.8 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 1.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.3 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
0.1 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.5 | GO:0007098 | centrosome cycle(GO:0007098) |
0.1 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.5 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.9 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 3.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.3 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.5 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 1.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.1 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.7 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.1 | 1.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 1.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.2 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 5.0 | GO:0034470 | ncRNA processing(GO:0034470) |
0.1 | 0.7 | GO:0070192 | chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.5 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.1 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 0.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.1 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.4 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.3 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 1.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 3.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.3 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.7 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.1 | 1.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.1 | 0.1 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.2 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 1.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.3 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 6.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0010743 | regulation of macrophage derived foam cell differentiation(GO:0010743) |
0.1 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.6 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.7 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.3 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 1.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.2 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.1 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.0 | 0.0 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 1.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.0 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.6 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.2 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 1.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.4 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 1.8 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.5 | GO:1903038 | negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.5 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.0 | 0.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.3 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.0 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0045017 | glycerolipid biosynthetic process(GO:0045017) |
0.0 | 0.0 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.0 | 0.2 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
0.0 | 0.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.0 | 0.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 1.5 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 4.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 1.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.0 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.0 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.0 | 1.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 6.9 | GO:0008091 | spectrin(GO:0008091) |
1.2 | 4.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.2 | 5.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 3.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.0 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.0 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.9 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 2.7 | GO:0031523 | Myb complex(GO:0031523) |
0.9 | 5.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.9 | 3.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 8.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 6.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 3.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.9 | 2.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.8 | 5.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 1.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 2.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 3.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 4.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 10.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 3.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 3.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 3.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 3.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 2.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.7 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 2.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.7 | 2.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.7 | 2.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 3.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 2.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 3.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.6 | 3.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 1.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 3.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 0.6 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.6 | 1.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 2.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.6 | 2.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.6 | 3.3 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.5 | 3.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 3.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 3.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 1.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 1.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.5 | 1.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 15.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.5 | 3.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 3.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 2.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 1.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 2.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 4.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.4 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 2.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 11.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.5 | 3.6 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 4.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 1.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 3.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 1.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 1.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 1.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 2.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 2.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 1.7 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 0.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 2.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 2.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 0.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 5.4 | GO:0031430 | M band(GO:0031430) |
0.4 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 5.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 1.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 2.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 5.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 3.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 0.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.4 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 2.9 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 4.0 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 21.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 0.4 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.4 | 2.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 5.6 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 13.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 1.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 2.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.3 | 1.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 30.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 3.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 3.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 1.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.9 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 3.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 2.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 0.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 10.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 3.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 2.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.1 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 1.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 2.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 3.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 9.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 11.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 3.5 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 17.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 4.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 6.1 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 2.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 2.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 14.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 0.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 2.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 2.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 3.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.7 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 2.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 9.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 2.6 | GO:0071010 | prespliceosome(GO:0071010) |
0.2 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 4.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 4.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 2.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 2.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 1.4 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 2.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 10.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 11.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 3.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 10.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 3.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 3.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 7.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 2.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 4.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 1.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.2 | 4.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 3.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 12.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 1.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.6 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 4.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 1.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 8.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 6.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 2.8 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 14.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 10.1 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 2.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 8.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 6.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 12.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 7.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 1.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.8 | GO:0044448 | cell cortex part(GO:0044448) |
0.2 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 3.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 23.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 3.4 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.8 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 1.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 4.1 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 1.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 1.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 42.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.5 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.2 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 8.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 8.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 3.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 4.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 1.8 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 3.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 1.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 1.3 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 1.3 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 3.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 4.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.3 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) XPC complex(GO:0071942) |
0.1 | 6.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 1.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 4.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 4.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 5.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 5.2 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 2.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 33.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 2.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.1 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 2.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 1.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 1.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 15.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.9 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 6.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 6.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 3.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.7 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 3.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 77.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 5.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 2.2 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 6.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 31.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.6 | GO:0005819 | spindle(GO:0005819) |
0.0 | 6.1 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 6.7 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.3 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.3 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 19.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.8 | GO:0097223 | sperm part(GO:0097223) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.0 | 6.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.6 | 9.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.5 | 3.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.5 | 4.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.4 | 5.5 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.4 | 4.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.3 | 3.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.2 | 4.8 | GO:0015265 | urea channel activity(GO:0015265) |
1.2 | 3.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 8.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.2 | 10.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.1 | 4.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 4.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.1 | 4.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.1 | 5.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.1 | 4.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.0 | 4.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.0 | 5.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 6.0 | GO:0008199 | ferric iron binding(GO:0008199) |
1.0 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 2.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.0 | 3.9 | GO:0009374 | biotin binding(GO:0009374) |
1.0 | 8.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.0 | 3.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 3.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.0 | 2.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 4.7 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.9 | 3.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.9 | 7.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 0.9 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.9 | 2.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 4.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 3.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 3.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.8 | 3.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 3.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 4.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 2.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.8 | 3.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 0.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 1.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 4.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 3.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 3.0 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.7 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.7 | 7.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 4.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 2.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.7 | 1.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 2.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 2.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 2.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 2.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 2.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 8.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 1.9 | GO:0019862 | IgA binding(GO:0019862) |
0.6 | 5.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 1.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 3.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 3.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 2.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.6 | 7.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 1.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 1.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 3.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 10.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 7.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 10.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 1.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 2.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 2.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 5.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 2.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 1.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 2.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 2.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 3.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 2.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 7.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 1.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.5 | 3.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 4.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 0.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 2.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 3.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 6.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 3.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 1.6 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.5 | 2.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 1.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 3.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.5 | 3.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 3.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 3.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 3.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 1.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 3.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 2.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 14.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 1.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.5 | 6.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.5 | 2.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 2.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 2.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 1.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 2.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 2.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 1.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 4.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 2.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 2.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 1.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 0.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 12.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 1.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 1.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 0.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.4 | 6.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 0.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 4.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 3.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 2.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 3.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 1.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 6.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 7.8 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 1.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 1.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 1.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 3.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 1.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 0.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 1.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 2.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 2.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 2.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 3.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 2.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 2.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 2.3 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.4 | 1.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 12.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 7.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.4 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 0.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 4.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.5 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 1.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 0.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 3.6 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 4.3 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 2.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 2.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.4 | 1.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 9.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 1.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.1 | GO:0032564 | dATP binding(GO:0032564) |
0.4 | 1.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.4 | 1.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 0.7 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 3.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 2.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 3.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 2.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 4.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.3 | 5.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 4.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 2.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 3.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 3.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 2.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 0.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 3.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 1.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 4.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 6.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 2.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 2.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 2.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 3.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 0.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.9 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 1.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 0.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 5.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 4.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 2.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 6.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 0.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.3 | 1.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 1.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 0.6 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.3 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 1.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 2.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 2.8 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 4.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 1.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 0.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 5.2 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 7.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 1.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 2.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 2.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.8 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 13.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 0.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 3.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 2.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 2.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 13.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 2.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 2.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 3.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.7 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 2.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 5.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 5.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 5.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 3.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 2.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 1.7 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 1.9 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 7.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 1.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 4.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.7 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 2.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 0.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 5.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 5.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.2 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.2 | 2.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.4 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.2 | 0.4 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 5.3 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 2.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 7.0 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 2.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 32.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 6.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 6.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.6 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 3.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 4.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 0.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 1.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 2.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 4.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 1.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 2.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 4.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.1 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 8.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 3.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 10.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 1.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 2.1 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 19.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 1.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 1.0 | GO:0050542 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 5.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 0.7 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.2 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 1.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 1.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.7 | GO:0071814 | low-density lipoprotein particle binding(GO:0030169) lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.2 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 21.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 1.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.6 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 3.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 1.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 3.9 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 1.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0018589 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 4.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.7 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 3.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 1.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 4.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 2.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 5.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 6.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.6 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.1 | 2.4 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 1.7 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 2.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 0.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.9 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 3.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 2.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 2.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 5.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 8.8 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 2.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 2.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 2.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 2.6 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 1.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 1.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.4 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 2.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 2.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 2.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.1 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 3.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 1.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 3.5 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 3.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 12.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 5.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.5 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 3.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 5.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 2.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.7 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 2.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.3 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 2.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 1.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.5 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 5.9 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 4.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 1.9 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.8 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 23.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 4.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 2.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 1.0 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 33.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 24.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.7 | 2.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 9.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 6.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 5.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 4.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 15.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 1.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 4.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 3.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 23.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 1.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 12.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 5.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 5.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 8.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 9.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 8.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 8.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 14.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 21.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 5.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 11.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 10.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 5.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 14.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 2.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 1.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 4.1 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 2.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 3.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 6.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 3.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 9.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 7.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 1.3 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 2.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 5.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 5.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 7.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 4.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 0.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 3.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 11.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 9.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 5.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 4.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 5.5 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 2.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 3.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 4.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 4.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 5.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 3.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 4.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 11.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 2.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.4 | 19.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 12.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.0 | 24.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.9 | 6.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 0.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 0.8 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.7 | 7.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.7 | 9.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 0.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.6 | 5.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 2.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 9.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 6.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 5.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 5.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 4.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 7.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 1.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 5.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.5 | 10.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 6.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 12.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 1.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 8.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 6.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 4.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 6.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 2.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 13.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 7.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 4.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 6.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 39.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 5.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 11.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.4 | 5.6 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.4 | 13.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 10.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 11.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 7.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 5.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 1.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 4.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 23.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 5.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 4.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 10.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 3.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 3.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 4.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 5.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 3.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 3.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 25.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 7.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 4.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 1.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 3.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 2.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 5.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 3.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 2.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 13.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 2.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 5.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 4.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 2.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 0.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 6.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 8.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 7.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.3 | 4.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 1.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 5.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 10.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 2.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 4.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 11.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 3.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 12.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 3.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 0.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 2.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 3.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 6.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 2.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 1.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 4.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 1.8 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 17.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 3.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 13.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.9 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.2 | 4.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 4.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 8.6 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.2 | 6.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 1.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 3.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 0.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 18.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 4.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 10.5 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 0.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.6 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 4.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 2.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.9 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 11.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.4 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 2.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 2.5 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.1 | 2.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 3.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |